Search results

Wolfgang Knecht, head of LP3 presented the capabilities of LP3 in biophysics and protein structure determination at the first Swedish national PI-meeting in Biochemistry, Biophysics and Molecular Biology (external webpage). The meeting was jointly organized by the Swedish Society for Biochemistry, Biophysics and Molecular Biology, SFBBM(external webpage, in Swedish) and the Swedish National Commit

https://www.lp3.lu.se/article/lp3-presented-swedish-national-pi-meeting-biochemistry-biophysics-and-molecular-biology - 2025-11-27

To strengthen the engagement of the Swedish scientific community in ESS, Sweden has now officially become part of the ESS in-kind community with four projects selected by ESS and the Swedish Research Council. To strengthen the engagement of the Swedish scientific community in the European Spallation Source (ESS), Sweden has now officially become part of the ESS in-kind community with a number of c

https://www.lp3.lu.se/article/sweden-enters-kind-agreement-ess-lp3-contributes-deuteration-lab-services - 2025-11-27

The Deuteration Network (DeuNet) is an international network which aims to facilitate access to deuteration services. The Deuteration Network (DeuNet) (external webpage) is an international network of deuteration facilities and laboratories which aims to facilitate access to deuteration services and customised deuterium labelling of molecules and biomolecules for use in neutron research and in oth

https://www.lp3.lu.se/article/new-deunet-webpage-now-launched - 2025-11-27

All staff from LP3, which is one out of five nodes in the PPS national infrastructure, participated. The distributed national research infrastructure Protein Production Sweden (PPS, see external website) did meet for its second annual staff retreat at Ljunglöfska slottet in Stockholm. The 25 staff researchers of PPS attending used the two day meeting (28/29th September 2023) to discuss and reflect

https://www.lp3.lu.se/article/annual-pps-retreat-stockholm - 2025-11-27

Recently, a book chapter with protocols for the Baculovirus Expression Vector System in insect cells was published by LP3. Lund Protein Production Platform (LP3) has recently published its standard operating procedures for recombinant protein expression using the Baculovirus Expression Vector System (BEVS) in insect cells. Read the full book chapter here at Springer Link (external website)LP3 prov

https://www.lp3.lu.se/article/new-publication-about-bevs-lp3 - 2025-11-27

Members of the board and scientific committee of PPS, Sabine Suppmann and Kim Remans, respectively are among the authors of a new review in Star Protocols about expression systems for recombinant protein production. The overview is based on a survey with 60 leading experts in protein production about their experiences and practices in using different expression systems for recombinant protein prod

https://www.lp3.lu.se/article/guide-choosing-expression-system-recombinant-proteins - 2025-11-27

Lund Protein Production Platform (LP3) is featured in EUGLOHRIA Talks and EUGLOHRIA Virtual Tours approaching audiences with interactive and innovative content and an interview with the head of LP3, Dr. Wolfgang Knecht, is now available on the EUGLOHRIA homepage. The European University Alliance for Global Health – Transformation through Joint Research and Innovation Action (EUGLOHRIA, external li

https://www.lp3.lu.se/article/lund-protein-production-platform-featured-euglohria-talks-and-euglohria-virtual-tours - 2025-11-27

At the first 2024 management meeting, SciLifeLab Lund welcomed LP3 as a new local core facility. The aim of the local SciLifeLab sites in Umeå, Linköping, Gothenburg and Lund is to bring national infrastructure activities closer to the research communities at these locations, and to contribute to increased synergies and collaborations with multiple stakeholders.SciLifeLab Lund (external webpage) w

https://www.lp3.lu.se/article/lp3-newest-local-core-facility-scilifelab-lund - 2025-11-27

LP3 with Celeste Sele presented its capabilities in Protein Characterisation, Crystallisation and Structure Determination at the 35th MAX IV user meeting in Lund (external homepage). LP3 is harboring a local node of Protein Production Sweden (PPS). PPS focuses on the production and purification of (mainly) recombinant protein reagents for all Swedish researchers. The Director of PPS, Malin Bäckstr

https://www.lp3.lu.se/article/lp3-and-pps-35th-max-iv-user-meeting - 2025-11-27

LP3 is now part of "Pandemics and Alertness", a collaboration initiative for virus-related topics by Lund University Pandermics and Alertness is an interdisciplinary platform created to promote collaboration and change of information between stakeholders, researchers and experts from different disciplines, and public authorities to improve our knowledge of the impact of pandemics on the society. A

https://www.lp3.lu.se/article/pandemics-and-alertness - 2025-11-27

Together with DEMAX (see external wesite), the Lund Protein Production Platform (LP3) recently published a new protocol for the use of algal autolysate for the production of deuterium-labeled recombinant protein featuring:Continuous cultivation and autolysis of deuterated B. brauniiAutolysate used as glycerol substitute in recombinant protein productionUsing autolysate gives high protein yield and

https://www.lp3.lu.se/article/demax-and-lp3-publish-new-protocol-use-algal-autolysate-production-deuterium-labeled-recombinant - 2025-11-27

InfraLife Project Coordinator, Claire Lyons, came for a site visit at LP3 InfraLife is a national initiative to improve knowledge and availability of infrastructures and make it accessible to Life science researchers in academia, industry and health care. Read more about the visit here at InfraLife news (external webpage).  More information about InfraLife can be found on the InfraLife homepage (e

https://www.lp3.lu.se/article/visit-infralife-lp3 - 2025-11-27

In a recent study from Lund University, researchers have discovered that metabolic changes in the blood cell, affect the development of blood during the fetal stage. They found a previously unknown metabolic regulator - a kind of switch - which turns out to be crucial for how different types of blood cells develop. In the long run, this could mean that natural killer cells, a type of white blood c

https://www.stemcellcenter.lu.se/article/increased-metabolism-mitochondria-resulted-higher-levels-natural-killer-cells - 2025-11-27

A multidisciplinary research team at Lund University has innovatively tackled what has long been a major problem in stem cell research. The project has now been awarded a Proof of Concept grant from the European Research Council, ERC. Jonas Larsson, Professor of Molecular Medicine, and his research colleague Ludwig Schmiderer, together with Martin Hjort, a researcher at NanoLund, have developed th

https://www.stemcellcenter.lu.se/article/how-nanostraws-can-increase-number-blood-stem-cells - 2025-11-27

Each year, Lund Stem Cell Center presents one of its members with its Article of the Year Award. This year three distinguished nominees contended for the title. Among them, Marie Jönsson, representing the research group Molecular Neurogenetics, was awarded Article of the Year 2021, for their work in revealing how the activation of ancient viruses during brain development causes inflammation. In th

https://www.stemcellcenter.lu.se/article/scc-article-year-award-goes - 2025-11-27

A team of researchers from Lund University and the Lund Stem Cell Center have developed a new memory-efficient tool for single-cell genomic analysis called Scarf. Now available in Nature Communications, this innovative, bioinformatics software has the potential to help researchers navigate a growing treasure trove of data and set them on the path to answering new scientific questions related to hu

https://www.stemcellcenter.lu.se/article/introducing-scarf-memory-efficient-solution-single-cell-genomic-analysis - 2025-11-27

Researchers at Lund University and Lund Stem Cell Center in Sweden have developed a new method for studying age-related brain disorders. The researchers have focused on the neurodegenerative disorder Huntington’s disease and the results have now been published in the journal Brain. Basic medical research often faces the challenge of developing disease models that correspond to specific disease mec

https://www.stemcellcenter.lu.se/article/researchers-reprogram-human-skin-cells-aged-neurons-study-neurodegenerative-disorders - 2025-11-27

Sofia Wijk will defend her Ph.D. thesis on the 8th of September 2022, with a vision to contribute to the development of future cell-based therapies for patients with chronic lung disease. She has dedicated the last several years to better understanding the regenerative properties and processes of stem cells in our airways. In this interview, she tells us about her research, her journey in academia

https://www.stemcellcenter.lu.se/article/phd-defence-interview-sofia-wijk - 2025-11-27

A large amount of lungs donated cannot be used for transplantation. Researchers at Lund Stem Cell Center, Lund University in Sweden and Skåne University Hospital have conducted an animal study bringing hope that more donor lungs could be used in the future. The researchers have launched a pilot study to investigate whether the treatment will have the same positive effects on human beings. About 19

https://www.stemcellcenter.lu.se/article/new-treatment-could-result-more-donor-lungs - 2025-11-27

Sarah Warsi will defend her Ph.D. thesis on the 4th of October 2022. Driven by the desire to improve patient outcomes, she has dedicated the last several years to studying both in the clinic and the lab. During that time, her research efforts have centered on a better understanding of the functionality and fate of blood stem cells to contribute to developing improved clinical therapies for patient

https://www.stemcellcenter.lu.se/article/phd-defence-interview-sarah-warsi - 2025-11-27